{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T21:09:53Z","timestamp":1768597793707,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,7,27]],"date-time":"2006-07-27T00:00:00Z","timestamp":1153958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2006,10,25]]},"DOI":"10.1007\/s00296-006-0164-x","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T13:10:20Z","timestamp":1153919420000},"page":"97-100","source":"Crossref","is-referenced-by-count":63,"title":["Treatment with anakinra in the hyperimmunoglobulinemia D\/periodic fever syndrome"],"prefix":"10.1007","volume":"27","author":[{"given":"Donato","family":"Rigante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Ansuini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Lisa","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Avallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,7,27]]},"reference":[{"key":"164_CR1","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0003-4967(24)43400-6","volume":"60","author":"P Picco","year":"2001","unstructured":"Picco P, Gattorno M, Di Rocco M, Buoncompagni A (2001) Non-steroidal anti-inflammatory drugs in the treatment of hyper-IgD syndrome. Ann Rheum Dis 60:904","journal-title":"Ann Rheum Dis"},{"key":"164_CR2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(84)92505-4","volume":"1","author":"JW Meer van der","year":"1984","unstructured":"van der Meer JW, Vosse JM, Radl J, van Nieuwkoop JA, Meyer CJ, Lobato S, van Furth R (1984) Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1:1087\u20131090","journal-title":"Lancet"},{"key":"164_CR3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.ejhg.5201323","volume":"13","author":"A D\u2019Osualdo","year":"2005","unstructured":"D\u2019Osualdo A, Picco P, Caroli F, Gattorno M, Giacchino R, Fortini P, Corona F, Tommasini A, Salvi G, Specchia F, Obici L, Meini A, Ricci A, Seri M, Ravazzolo R, Martini A, Ceccherini I (2005) MVK mutations and associated clinical features in Italian patients affected with autoinflammatrory disorders and recurrent fever. Eur J Hum Genet 13:314\u2013320","journal-title":"Eur J Hum Genet"},{"key":"164_CR4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.ejhg.5200933","volume":"11","author":"SM Houten","year":"2003","unstructured":"Houten SM, van Woerden CS, Wijburg FA, Wanders RJ, Waterham HR (2003) Carrier frequency of the V377I (1129G>A) MVK mutation, associated with hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet 11:196\u2013200","journal-title":"Eur J Hum Genet"},{"key":"164_CR5","first-page":"525","volume":"18","author":"J Frenkel","year":"2000","unstructured":"Frenkel J, Houten SM, Waterham HR, Wanders RJA, Rijkers GT, Kimpen JLL, Duran R, Poll-The BT, Kuis W (2000) Mevalonate kinase deficiency and Dutch type periodic fever. Clin Exp Rheumatol 18:525\u2013532","journal-title":"Clin Exp Rheumatol"},{"key":"164_CR6","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1212\/01.WNL.0000115390.33405.F7","volume":"62","author":"A Simon","year":"2004","unstructured":"Simon A, Kremer HP, Wevers RA, Scheffer H, De Jong JG, Van der Meer JW, Drenth JP (2004) Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology 62:994\u2013997","journal-title":"Neurology"},{"key":"164_CR7","first-page":"925","volume":"28","author":"J Dios Garcia-Diaz de","year":"2001","unstructured":"de Dios Garcia-Diaz J, Alvarez-Blanco MJ (2001) Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome. J Rheumatol 28:925\u2013926","journal-title":"J Rheumatol"},{"key":"164_CR8","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0022-3565(24)29496-9","volume":"298","author":"JP Drenth","year":"2001","unstructured":"Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther 298:1221\u20131226","journal-title":"J Pharmacol Exp Ther"},{"key":"164_CR9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.11218","volume":"48","author":"K Takada","year":"2003","unstructured":"Takada K, Aksentijevich I, Mahadevan V, Dean JA, Kelley RI, Kastner DL (2003) Favorable preliminary experience with etanercept in two patients with the hyperimunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 48:2645\u20132651","journal-title":"Arthritis Rheum"},{"key":"164_CR10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","volume":"75","author":"A Simon","year":"2004","unstructured":"Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF, Drenth JP (2004) Simvastatin treatment for inflammatory attacks of the hyperimunoglobulinaemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476\u2013483","journal-title":"Clin Pharmacol Ther"},{"key":"164_CR11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.rdc.2004.01.005","volume":"30","author":"SB Cohen","year":"2004","unstructured":"Cohen SB (2004) The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 30:365\u2013380","journal-title":"Rheum Dis Clin North Am"},{"key":"164_CR12","first-page":"119","volume":"23","author":"HE Langer","year":"2003","unstructured":"Langer HE, Missler-Karger B (2003) Kineret: efficacy and safety in daily clinical practice: an interim analysis of the Kineret response assessment initiative (kreative) protocol. Int J Clin Pharmacol Res 23:119\u2013128","journal-title":"Int J Clin Pharmacol Res"},{"key":"164_CR13","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","volume":"364","author":"HM Hoffman","year":"2004","unstructured":"Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, Anderson JP, Wanderer AA, Firestein GS (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364:1779\u20131785","journal-title":"Lancet"},{"key":"164_CR14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","volume":"50","author":"PN Hawkins","year":"2004","unstructured":"Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50:607\u2013612","journal-title":"Arthritis Rheum"},{"key":"164_CR15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/keh547","volume":"44","author":"B Granel","year":"2005","unstructured":"Granel B, Serratrice J, Disdier P, Weiller PJ (2005) Dramatic improvement with anakinra in a case of chronic infantile neurological cutaneous and articular (CINCA) syndrome. Rheumatology 44:689\u2013690","journal-title":"Rheumatology"},{"key":"164_CR16","first-page":"260","volume":"63","author":"EJ Bodar","year":"2005","unstructured":"Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 63:260\u2013264","journal-title":"Neth J Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-006-0164-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-006-0164-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-006-0164-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:48:37Z","timestamp":1736477317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-006-0164-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,27]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,10,25]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1007\/s00296-006-0164-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,27]]}}}